Bill Snyder
-
Founders’ Celebration for Institute of Chemical Biology set for March 28
The Vanderbilt Institute of Chemical Biology (VICB) will hold a Founders’ Celebration mini-symposium on March 28 to acknowledge the contributions of its founders, Lawrence Marnett, PhD, and Ned Porter, PhD, and to celebrate 15-plus years of success as a trans-institutional scientific incubator. Read MoreMar 22, 2018
-
Study tracks protein’s role in stem cell function
MCL-1 is a member of the BCL-2 family of proteins important for blocking apoptosis, or programmed cell death. Many types of cancer cells escape the body’s effort to kill them by overexpressing MCL-1. Read MoreMar 22, 2018
-
Volunteers sought for bird flu vaccine trial
Vanderbilt University Medical Center is recruiting volunteers to participate in a national study of an investigational vaccine against the H7N9 influenza virus, also known as “bird flu.” Read MoreMar 15, 2018
-
MIT’s Wittrup set for March 22 Flexner Discovery Lecture
K. Dane Wittrup, PhD, a pioneer in protein engineering technologies who has helped accelerate development of antibody therapies for cancer, will deliver the next Flexner Discovery Lecture on Thursday, March 22. Read MoreMar 15, 2018
-
Long QT syndrome – revealed
Vanderbilt investigators have used sophisticated cell biological and structural techniques to “classify” mutations in potassium channels, studies that could lead to personalized treatment of heart rhythm disorders. Read MoreMar 12, 2018
-
Discovery by Vanderbilt-led group could lead to improved diabetes treatment
Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D). Read MoreMar 6, 2018
-
Graphene material strengthens nerve signaling in the brain
Less than 20 years after it was developed, a thin, resilient sheet of carbon atoms with remarkable properties known as graphene is transforming biomedical fields as far flung as tissue engineering, neuroprosthetics and drug discovery. Read MoreMar 1, 2018
-
Hope for an RSV vaccine
Newly discovered features in an RSV protein may be useful for rational structure-based vaccine design. Read MoreFeb 23, 2018
-
Brain Awareness events highlight mind’s wonders
Research on circadian rhythms, longevity and the brain’s pleasure system will be featured during this year’s Brain Awareness events sponsored by the Vanderbilt Brain Institute. Read MoreFeb 22, 2018
-
Vanderbilt’s Gamazon named visiting fellow at Cambridge University
Eric Gamazon, PhD, research instructor in the Division of Genetic Medicine at Vanderbilt University School of Medicine, is spending part of the academic year at Cambridge University in England as one of 40 Clare Hall Visiting Fellows. Read MoreFeb 15, 2018
-
Noted neuroscientist Gouaux set for Discovery Lecture
Eric Gouaux, PhD, whose work has helped reveal the molecular mechanisms by which nerve cells communicate, will deliver the next Flexner Discovery Lecture Thursday, Feb. 22. Read MoreFeb 15, 2018
-
Event showcases REDCap’s data management versatility
Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe. Read MoreFeb 8, 2018
-
Study helps map signaling system in brain linked to ASD
Researchers at Vanderbilt University have worked out part of the “wiring diagram” of a signaling system in the brain that has been linked to autism spectrum disorder (ASD). Read MoreFeb 8, 2018
-
Partnership enhances eye care for Ebola survivors in Liberia
Vanderbilt University School of Medicine (VUSM), the Vanderbilt Institute for Global Health (VIGH) and the Vanderbilt Eye Institute (VEI) have joined forces with partners in Liberia to strengthen medical education and increase access to ophthalmology care in the aftermath of the 2014-2015 West African Ebola epidemic that killed more than 11,000 people. Read MoreFeb 8, 2018
-
AAAS, chemistry society honor Lindsley’s research contributions
Craig Lindsley, PhD, co-director of the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD), has been named a fellow of the Royal Society of Chemistry and elected chair-elect of the Section of Pharmaceutical Sciences of the American Association for the Advancement of Science (AAAS). Read MoreFeb 1, 2018
-
Research Staff Awards honor lab, administrative excellence
Laboratory and administrative personnel at Vanderbilt University School of Medicine were honored last week for research excellence during the 14th annual Research Staff Awards luncheon at the University Club. Read MoreFeb 1, 2018
-
NEJM Catalyst forum addresses mental, behavioral and social health determinants
Healthcare is more than diagnosing and treating disease. To truly improve health outcomes for individuals and communities, the mental, behavioral and social determinants of health must be fully integrated with physical factors at all levels of the healthcare system. Read MoreJan 29, 2018
-
Versatile C. difficile blocker
New research reveals a unique mechanism of C. difficile toxin neutralization by a monoclonal antibody, suggesting new therapeutic approaches. Read MoreJan 26, 2018
-
Directorships honor VUMC’s critical missions
Vanderbilt University Medical Center (VUMC) on Monday held its first Directorship Celebration to honor and support eight of its leaders in clinical care, research, education and administration. Read MoreJan 25, 2018
-
Study may point to new ways to reverse insulin resistance
Researchers at Vanderbilt University have discovered how insulin crosses the capillary endothelium to exit blood vessels and stimulate skeletal muscle cells — a major finding that may lead to new ways to reverse insulin resistance, a hallmark of type 2 diabetes. Read MoreJan 25, 2018